Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Inge A. M. van den Oever"'
Publikováno v:
Mediators of Inflammation, Vol 2010 (2010)
Endothelial dysfunction is regarded as an important factor in the pathogenesis of vascular disease in obesity-related type 2 diabetes. The imbalance in repair and injury (hyperglycemia, hypertension, dyslipidemia) results in microvascular changes, in
Externí odkaz:
https://doaj.org/article/6fc9090c9c7e495e8dc2ed69f2adb56b
Autor:
Dirkjan van Schaardenburg, Maaike Heslinga, Alexandre E. Voskuyl, Rob Schotsman, Ed N. Griep, Willem F. Lems, Inge A. M. van den Oever, Micheal T. Nurmohamed, Yvo M. Smulders, Ben A. C. Dijkmans, Mike J L Peters, H. Griep-Wentink, Maarten Boers, Walter Cambach
Publikováno v:
van den Oever, I A M, Heslinga, M, Griep, E N, Griep-Wentink, H R M, Schotsman, R, Cambach, W, Dijkmans, B A C, Smulders, Y M, Lems, W F, Boers, M, Voskuyl, A E, Peters, M J L, van Schaardenburg, D & Nurmohamed, M T 2017, ' Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project ', Rheumatology, vol. 56, no. 9, pp. 1472-1478 . https://doi.org/10.1093/rheumatology/kew497
Rheumatology, 56(9), 1472-1478. Oxford University Press
Rheumatology (Oxford, England), 56(9), 1472-1478. Oxford University Press
Rheumatology, 56(9), 1472-1478. Oxford University Press
Rheumatology (Oxford, England), 56(9), 1472-1478. Oxford University Press
Objective To assess the 10-year cardiovascular (CV) risk score and to identify treatment and undertreatment of CV risk factors in patients with established RA. Methods Demographics, CV risk factors and prevalence of cardiovascular disease (CVD) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52e47a24060d9c627707aa4b98c0ad05
https://research.vumc.nl/en/publications/c63f2254-3396-4057-a474-35894bbe32d8
https://research.vumc.nl/en/publications/c63f2254-3396-4057-a474-35894bbe32d8
Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion
Publikováno v:
Therapeutic Advances in Cardiovascular Disease, 5(4), 166-181. SAGE Publications Ltd
van den Oever, I A, van Sijl, A M & Nurmohamed, M T 2013, ' Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. ', Therapeutic Advances in Cardiovascular Disease, vol. 5, no. 4, pp. 166-181 . https://doi.org/10.1177/1759720x13491025
van den Oever, I A, van Sijl, A M & Nurmohamed, M T 2013, ' Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. ', Therapeutic Advances in Cardiovascular Disease, vol. 5, no. 4, pp. 166-181 . https://doi.org/10.1177/1759720x13491025
The risk of cardiovascular morbidity and mortality is increased in rheumatoid arthritis. The classical cardiovascular risk factors, including smoking, hypertension, dyslipidaemia, insulin resistance and diabetes mellitus, obesity and physical inactiv
Autor:
Michael T. Nurmohamed, S. Simsek, Casper G. Schalkwijk, Alexandre E. Voskuyl, Paul A.J. Krijnen, Inge A. M. van den Oever, Umit Baylan, Alper M. van Sijl, Marieke M. ter Wee, Hans W.M. Niessen
Publikováno v:
van den Oever, I A M, van Sij, A M, Baylan, U, ter Wee, M M, Schalkwijk, C G, Krijnen, P A J, Nurmohamed, M T, Voskuyl, AE, Niessen, H W M & Simsek, S 2016, ' Comparing inflammatory cell density in the myocardium and coronary arteries in rheumatoid arthritis patients versus controls with myocardial infarction : A post-mortem case-control study ', International Journal of Cardiology, vol. 209, pp. 74-76 . https://doi.org/10.1016/j.ijcard.2016.02.065
International Journal of Cardiology, 209, 74-76. Elsevier Ireland Ltd
International Journal of Cardiology, 209, 74-76. Elsevier Ireland Ltd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c4dd6748e28d738b511ed870bd7f99
https://research.vumc.nl/en/publications/b665aeec-7bbb-4d87-8932-b6c58e064054
https://research.vumc.nl/en/publications/b665aeec-7bbb-4d87-8932-b6c58e064054
Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
Autor:
Michael T. Nurmohamed, Inge A. M. van den Oever, Irene E. van der Horst-Bruinsma, S.C. Heslinga, Mike J L Peters, Yvo M. Smulders, Alper M. van Sijl
Publikováno v:
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, 16:80. BioMed Central
Heslinga, S C, van den Oever, I A, van Sijl, A M, Peters, M J, van der Horst-Bruinsma, I E, Smulders, Y M & Nurmohamed, M T 2015, ' Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation ', BMC Musculoskeletal Disorders, vol. 16, 80 . https://doi.org/10.1186/s12891-015-0532-3
BMC Musculoskeletal Disorders, 16:80. BioMed Central
Heslinga, S C, van den Oever, I A, van Sijl, A M, Peters, M J, van der Horst-Bruinsma, I E, Smulders, Y M & Nurmohamed, M T 2015, ' Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation ', BMC Musculoskeletal Disorders, vol. 16, 80 . https://doi.org/10.1186/s12891-015-0532-3
Background Ankylosing spondylitis (AS) is an inflammatory disease with documented elevated cardiovascular (CV) risk due to systemic inflammation and a higher prevalence of CV risk factors. CV risk management (CV-RM) could be an effective method to re
Publikováno v:
Journal of rheumatology, 40(6), 825-830. Journal of Rheumatology
Jamnitski, A, Levels, J H, van den Oever, I A & Nurmohamed, M T 2013, ' High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study ', Journal of Rheumatology, vol. 40, no. 6, pp. 825-830 . https://doi.org/10.3899/jrheum.121358
Journal of Rheumatology, 40(6), 825-830. Journal of Rheumatology
Jamnitski, A, Levels, J H, van den Oever, I A & Nurmohamed, M T 2013, ' High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study ', Journal of Rheumatology, vol. 40, no. 6, pp. 825-830 . https://doi.org/10.3899/jrheum.121358
Journal of Rheumatology, 40(6), 825-830. Journal of Rheumatology
Objective.We investigated changes in high-density lipoprotein (HDL) profiling in patients with rheumatoid arthritis who started treatment by taking tumor necrosis factor (TNF) inhibitors. The patients were stratified for European League Against Rheum
Publikováno v:
Mediators of Inflammation, Vol 2010 (2010)
Mediators of Inflammation, 2010:792393. Hindawi Publishing Corporation
Mediators of Inflammation
van den Oever, I A M, Raterman, H G, Nurmohamed, M T & Simsek, S 2010, ' Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus ', Mediators of Inflammation, vol. 2010, 792393 . https://doi.org/10.1155/2010/792393
Mediators of Inflammation, 2010:792393. Hindawi Publishing Corporation
Mediators of Inflammation
van den Oever, I A M, Raterman, H G, Nurmohamed, M T & Simsek, S 2010, ' Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus ', Mediators of Inflammation, vol. 2010, 792393 . https://doi.org/10.1155/2010/792393
Endothelial dysfunction is regarded as an important factor in the pathogenesis of vascular disease in obesity-related type 2 diabetes. The imbalance in repair and injury (hyperglycemia, hypertension, dyslipidemia) results in microvascular changes, in